The Predictive Ability of the CHADS2 and CHA2DS2-VASc Scores for Bleeding Risk in Atrial Fibrillation: The MAQI2 Experience-Reference-Cited by-同舟云学术

The Predictive Ability of the CHADS2 and CHA2DS2-VASc Scores for Bleeding Risk in Atrial Fibrillation: The MAQI2 Experience

Published:2014-08 Issue:2 Volume:134 Page:294-299
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Barnes Geoffrey D.^ORCID,Gu Xiaokui,Haymart Brian,Kline-Rogers Eva,Almany Steve,Kozlowski Jay^ORCID,Besley Dennis,Krol Gregory D.,Froehlich James B.,Kaatz Scott

Publisher

Elsevier BV

Subject

Hematology

Reference40 articles.

1. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann Intern Med,2007

2. Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patients;Palareti;Thromb Haemost.,2009

3. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;You;Chest,2012

4. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation;Gage;JAMA,2001

5. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation;Lip;Chest,2010

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of thrombocytopenia on bleeding and vascular events in atrial fibrillation;Blood Advances;2023-12-15

2. Prediction of bleeding in patients being considered for venous thromboembolism prophylaxis;Journal of Vascular Surgery: Venous and Lymphatic Disorders;2023-11

3. Comparison of Various Regimens of Antithrombotic Therapy in Patients With Valvular Heart Disease and Coronary Artery Disease After Surgical and Interventional Interventions;Kardiologiia;2023-07-28

4. Oral Anticoagulation in Patients With Advanced Chronic Kidney Disease and Atrial Fibrillation: Beyond Anticoagulation;Mayo Clinic Proceedings;2023-05

5. Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations;JAMA Network Open;2022-07-14